Browse All

Current Filters

CLEAR FILTER x

TITLE

Ocrelizumab and Cladribine had similar EDSS stability and safety profile in patients with highly active multiple sclerosis

Evaluating the Effect of Disease Duration in High Efficacy Versus Mid Efficacy Disease Modifying Therapies: Could This Help in Deciding When to De-escalate?

Efficacy and Safety Profile of Cladribine Tablets in an Italian Real-Life Cohort of Relapsing-Remitting Multiple Sclerosis Patients: A Monocentric Longitudinal Observational Study